
Pharmacally
MS
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in MS
Clinical TrialsBMS’s Zola-cel Shows Early Promise in Relapsing and Progressive MSBristol Myers Squibb has reported interim Phase 1 Breakfree-2 findings for zola-cel in highly active relapsing and progressive multiple sclerosis.Fact-Checked
Clinical TrialsRoche Reports Reduced Chronic Lesion Activity Across MS TrialsRoche reported Phase III findings showing that investigational fenebrutinib reduced slowly expanding lesion volume in relapsing and primary progressive multiple sclerosis, while reducing paramagnetic rim lesion accumulation in…Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.